NEW YORK (NEXSTAR) – Pfizer has submitted research to the U.S. Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children as it moves closer to seeking approval for expanded ...

(AP) — Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon — a key step toward beginning vaccinations for ...

Pfizer says kid-size doses of its COVID-19 vaccine are safe and nearly 91% effective at preventing infections in elementary school children. Details of the study were posted online Friday. FDA ...

Pfizer is seeking emergency use authorization for its COVID-19 booster vaccine shot for children ages 5 to 11. The company said it submitted its application to the Food and Drug Administration on ...

NEW YORK - Pfizer-BioNTech on Friday requested to expand the emergency use of its COVID-19 vaccine in the United States for older children ages 12 to 15. The request asks the U.S. Food and Drug ...

Children as young as 5 can now receive the Pfizer COVID-19 vaccine. Centers for Disease Control Director Dr. Rochelle Walensky signed off on a recommendation for an emergency use authorization for ...

Anxiety is high among parents as more kids head back to school without the protection of a COVID-19 vaccine for at least a few more months. Parents have a reason to be concerned. After months of ...

Pfizer and BioNTech announced Tuesday that they had submitted data to the Food and Drug Administration in the hopes of having their COVID-19 vaccine approved for emergency use in kids aged 5 to 12. In ...

Pfizer says its COVID-19 vaccine is safe and strongly protective in kids as young as 12. The findings of Pfizer's trial, released Wednesday, showed that the vaccine recorded 100% efficacy against the ...